Skip to main content
. 2023 Apr 4;58:101932. doi: 10.1016/j.eclinm.2023.101932

Table 1.

Database characteristics.

Name Country Data provenance Dates covered YYYY/MM Total persons % F Ages covered mean age (IQR) Patients with COVID-19 # Pre-pandemic background population # Measurements with values
APHM FR EHR 1998/11–2021/07 2,465,265 51.9 40 (21–60) 11,431 673,031 N
CPRD_AURUM UK GP 1995/01–2021/03 39,879,547 51.8 31 (18–44) 587,886 14,094,032 Y
CU_AMC US EHR 2011/01–2022/04 4,795,392 54.0 39 (22–56) 72,648 830,579 Y
CUIMC US EHR 1985/03–2021/08 6,808,470 55.8 38 (21–56) 28,044 1,197,983 Y
FIIBAPa ES EHR 2001/03–2021/10 292,305 54.7 41 (23–58) 7138 78 N
HIC SC EHR 2005/01–2021/12 1,254,464 50.4 45 (28–66) 11,813 885,236 Y
IBM_CCAE US Claims 2000/01–2021/07 159,440,276 51.1 31 (17–46) 983,089 23,483,191 N
IBM_MDCD US Claims 2006/01–2020/12 32,806,887 56.2 24 (5–38) 196,997 11,810,505 N
IBM_MDCR US Claims 2000/01–2021/07 10,356,249 55.3 72 (65–77) 41,542 1,467,963 N
IMASIS ES EHR 1990/02–2021/07 976,524 47.4 38 (23–54) 9330 198,012 Y
IPCI NL GP 2006/01–2021/06 2,529,355 51.2 37 (18–55) 91,759 1,329,674 Y
IQVIA_FRANCE_DA FR GP 2016/07–2021/06 3,767,012 52.3 38 (18–56) 2859 1,394,912 N
IQVIA_GERMANY_DA DE GP 2011/04–2021/03 30,780,239 55.7 44 (25–62) 45,508 9,040,531 N
IQVIA_OPENCLAIMS US Claims 2000/01–2021/10 306,000,000 52.6 34 (14–52) 17,848,443 306,000,000 N
IQVIA_PHARMETRICS US Claims 2013/01–2021/09 166,422,594 50.6 38 (19–50) 1,593,578 46,947,246 N
IU TR EHR 2018/01–2021/10 899,515 53.0 35 (18–52) 6194 619 Y
JMDC JP Claims 2005/01–2021/03 12,541,088 48.6 32 (19–46) 17,564 6,680,196 N
MHD BE EHR 2015/07–2021/12 117,131 50.9 52 (29–70) 203 23,754 N
OPTUM_EHR US EHR 2007/01–2021/03 99,454,715 53.3 37 (19–56) 693,334 41,281,147 Y
OPTUM_SES US Claims 2000/05–2021/06 90,285,937 50.5 36 (19–52) 899,986 17,212,611 Y
SIDIAP ES GP 2003/01–2021/06 8,022,374 50.1 35 (17–51) 495,237 5,934,449 Y
STARR US EHR 2008/01–2022/04 3,475,673 53.6 36 (18–54) 31,928 1,118,549 Y
U_OF_TARTUb EE Claims 2021/01–2021/02 386,557 53.2 39 (21–57) 84,957 376,842 N
UCCS RS EHR 2018/10–2021/03 823,962 54.1 51 (35–67) 16,764 49,643 Y
UCHDWa US EHR 2012/01–2022/05 316,119 53.8 37 (12–54) 61,037 240,831 Y
UK_BIOBANK UK EHR + Registry 1970/02–2020/07 502,504 54.4 58 (40–69) 1717 458,889 Y
Total 945,520,607 23,840,986 492,730,503

APHM = Health Data Warehouse of Assistance Publique - Hopitaux de Marseille, BE = Belgium, CPRD_AURUM = Clinical Practice Research Datalink AURUM, CU_AMC = University of Colorado Anschutz Medical Campus- Health Data Compass, CUIMC = Columbia University Irving Medical Center, DE = Germany, EE = Estonia, EHR = Electronic Health Record, ES = Spain, F = Female, FIIBAP = Fundación para la Investigación e Innovación Biosanitaria en Atención Primaria COVID19, FR = France, GP = General Practitioner, HIC = Health Informatics Centre, IBM_CCAE = IBM® MarketScan® Commercial Claims and Encounters Database, IBM_MDCD = IBM® MarketScan® Multi-State Medicaid Database, IBM_MDCR = IBM® MarketScan® Medicare Supplemental and Coordination of Benefits Database, IMASIS = Parc de Salut Mar Barcelona Information System, IPCI = Integrated Primary Care Information, IQR = Interquartile Range, IQVIA_FRANCE_DA = IQVIA Disease Analyzer France, IQVIA_GERMAN_DA = IQVIA Disease Analyzer Germany, IQVIA_OPENCLAIMS = IQVIA LRxDX Open Claims, IQVIA_PHARMETRICS = IQVIA Pharmetrics, IU = Istanbul Faculty of Medicine, Istanbul University, JP = Japan, MHD = Medaman Hospital Data, N = No, NL = The Netherlands, OPTUM_EHR = Optum® de-identified Electronic Health Record Dataset, OPTUM_SES = Optum De-Identified Clinformatics® Data Mart Database - Socio-Economic Status, RS = Serbia, SC = Scotland, SIDIAP = The Information System for Research on Primary Care, STARR = STAnford medicine Research data Repository-OMOP, TR = Turkey, U_OF_TARTU = University of Tartu (U_OF_TARTU), UCCS = University Clinical Center of Serbia, UCHDW = University of California Health Data Warehouse, UK = United Kingdom, UK_BIOBANK = UK Biobank, US = United States, Y = Yes.

a

COVID-19 only subset.

b

COVID-19 + Controls.